Moreover, a recent report analyzing a small cohort of patients with CLL (n=75) in conjunction with studies involving the TCL1 mouse model, an established mouse model of B-CLL, showed that miR34a, a p53 downstream pro-apoptotic target gene expression correlates with Mdm2SNP309 status [27]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.